Perspective Therapeutics is a medical - devices company in the healthcare sector trading on AMEX, led by CEO Johan Spoor, with a market cap of $463.7M.
Common questions about Perspective Therapeutics
Perspective Therapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $222.3K.
Perspective Therapeutics has approximately 119 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.